Feed SDZNY
SD

Sandoz Group AG

SDZNY · OTC

$81.82 +0.91% (+$0.74)
1M -9.67%
Market Cap $35.1B
P/E Ratio 38.16x
Div. Yield 1.26%
ROE 10.40%

Bulios Fair Price

$63.08

22.9% downside

Trenutna cena

$81.82

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica SDZNY trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Moderate
4/9
Valuation
31 /100
Expensive
P/E 38.16x
EV/EBITDA 22.76x
P/S 3.15x
Growth
44 /100
Stable
EPS growth 2.31%
Rev. growth 6.22%
FCF growth 0.49%
Profitability
65 /100
Moderate
Gross margin 47.02%
Net margin 8.24%
Op. margin 15.38%
Quality
45 /100
Average
ROIC 8.21%
ROE 10.40%
ROA 4.17%
Debt
64 /100
Moderate
Debt/Equity 0.61x
Current ratio 1.18x
Int. coverage 7.75x
Stability
74 /100
Stable
Beta 0.49x
Rev. volatility 18.16%
Profitable years 6

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o SDZNY
Online

O podjetju

Sandoz Group AG is a Swiss pharmaceutical company specializing in the production of generic drugs and biosimilar products. Founded in 1886, it is now a part of the Novartis group. Sandoz is one of the global leaders in generics, producing drugs that are identical to original products but more affordable. The company focuses on areas such as oncology, cardiovascular diseases, neurology, and infections. Sandoz is known for its innovation in biotechnology, providing high-quality, safe, and affordable treatments to patients worldwide.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Richard Saynor

Employees

23,000

Headquarters

Basel

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.